David J. Elliot

SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) “PROBES” FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES

Verawan Uchaipichat, Peter I. Mackenzie, David J. Elliot et al. · Drug Metabolism and Disposition · 2005 · 248 citations

Medicine, Biochemistry, Pharmacology +12

IN VITRO CHARACTERIZATION OF LAMOTRIGINE N2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTION

Andrew Rowland, David J. Elliot, J. Andrew Williams et al. · Drug Metabolism and Disposition · 2006 · 224 citations

Life Sciences, Biochemistry, Pharmacology +17

Quantitative prediction of<i>in vivo</i>inhibitory interactions involving glucuronidated drugs from<i>in vitro</i>data: the effect of fluconazole on zidovudine glucuronidation

Verawan Uchaipichat, Leanne K. Winner, Peter I. Mackenzie et al. · British Journal of Clinical Pharmacology · 2006 · 176 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Andrew Rowland, David J. Elliot, Peter I. Mackenzie et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 166 citations

Life Sciences, Biochemistry, Pharmacology +13

Characterization of Niflumic Acid as a Selective Inhibitor of Human Liver Microsomal UDP-Glucuronosyltransferase 1A9: Application to the Reaction Phenotyping of Acetaminophen Glucuronidation

John O. Miners, Kushari Bowalgaha, David J. Elliot et al. · Drug Metabolism and Disposition · 2011 · 105 citations

Life Sciences, Biochemistry, Pharmacology +14